Many people in natural health communities share a deep distrust of the pharmaceutical industry and big medicine. That distrust did not come from nowhere. Over the past few decades, several companies have put profits ahead of patients, with devastating results.
But the full story is more useful than simple outrage. Each of these scandals was exposed by journalists, whistleblowers, doctors, scientists, and courts, and each teaches lessons that can help you protect yourself and your family. Here are three of the most important cases, what we learned, and practical steps you can take.
Key Takeaways
- Purdue Pharma’s aggressive marketing of OxyContin helped fuel the opioid crisis. In 2025, a court approved a $7.4 billion settlement.
- Merck’s painkiller Vioxx was withdrawn in 2004 after evidence showed it raised the risk of heart attacks and strokes.
- Theranos falsely claimed it could run hundreds of tests on a drop of blood. Its founder was convicted of fraud.
- In 2025, drug and device companies reported $14.67 billion in payments and transfers to U.S. doctors and hospitals, all searchable in a public database.
- Being an informed, questioning patient is the best protection, while still using treatments that are proven to work.
Case 1: OxyContin and the Opioid Crisis
When Purdue Pharma launched OxyContin in 1996, it marketed the long-acting opioid as having a low risk of addiction. Sales representatives were trained to reassure doctors, and the company funded educational programs that encouraged wider opioid prescribing for common pain. Those claims turned out to be badly wrong.
Prescription opioids became the first wave of an addiction and overdose epidemic that later shifted to heroin and illicit fentanyl. Hundreds of thousands of Americans have died from opioid overdoses since the late 1990s.
Purdue pleaded guilty to federal criminal charges in 2007 and again in 2020. After years of litigation by states, cities, and victims, a bankruptcy judge approved a $7.4 billion settlement in November 2025, including contributions from the Sackler family that owned the company. Under the plan, the Sacklers will no longer be involved with the company, Purdue is barred from marketing opioids and lobbying, and the company will be owned by an independent foundation. The money is to be paid over 15 years for addiction treatment, prevention, and recovery programs.
The lesson: Marketing is not evidence. Be cautious when any product, prescription or supplement, is promoted as having big benefits and few risks.
Case 2: Vioxx
Vioxx (rofecoxib) was an anti-inflammatory painkiller approved in 1999 and heavily marketed as easier on the stomach than older drugs. Millions of people took it for arthritis and pain.
Warning signs about heart risks emerged within a few years. In September 2004, Merck voluntarily withdrew Vioxx after a clinical trial confirmed an increased risk of heart attacks and strokes. Later analyses, including research by FDA scientist Dr. David Graham, estimated the drug may have contributed to tens of thousands of serious heart problems in the United States. Internal documents released during lawsuits suggested the company had downplayed early safety concerns. Merck agreed to a $4.85 billion settlement in 2007 to resolve thousands of claims.
The lesson: New drugs have shorter safety track records. For common conditions, a well-established treatment with decades of data is often a safer first choice than the newest option.
Case 3: Theranos
Theranos, a Silicon Valley startup founded by Elizabeth Holmes, claimed its technology could run hundreds of medical tests on a few drops of blood from a finger prick. It raised hundreds of millions of dollars and partnered with a major pharmacy chain to offer tests to the public.
The technology did not work as claimed. Investigative reporting by the Wall Street Journal‘s John Carreyrou, beginning in 2015, along with whistleblowers inside the company, revealed that many results were unreliable. Patients received inaccurate test results that could have led to dangerous decisions. Holmes was convicted of fraud in 2022 and sentenced to more than 11 years in prison.
The lesson: Extraordinary claims require extraordinary evidence, whether they come from a tech startup, a drug company, or a supplement seller.
Follow the Money: Industry Payments to Doctors
Since 2013, the federal Open Payments program has required drug and medical device manufacturers to report payments to doctors, other clinicians, and teaching hospitals. For the 2025 program year, companies reported:
Open Payments: 2025 Program Year
| Type | Amount |
|---|---|
| Research payments | $9.50 billion |
| General payments (meals, consulting, speaking, travel) | $3.92 billion |
| Ownership and investment interests | $1.25 billion |
| Total | $14.67 billion |
Source: Centers for Medicare & Medicaid Services.
Not every payment is a problem. Much of the money funds legitimate research. But studies have found that even small payments, like a sponsored meal, are associated with doctors prescribing more of the sponsoring company’s brand-name drugs. Anyone can look up their doctor for free at openpaymentsdata.cms.gov.
A Balanced View
These scandals are real, and anger about them is justified. But it is important not to throw out the good with the bad. Vaccines, antibiotics, insulin, cancer treatments, and blood pressure medicines have saved hundreds of millions of lives. And the “natural” market has its own problems: supplements are not reviewed by the FDA before sale, and some have been found to contain hidden drugs, contaminants, or far less of the active ingredient than labeled.
The healthiest stance is not blind trust or blanket rejection, but informed skepticism: asking for evidence, wherever a claim comes from.
How to Protect Yourself: A Patient’s Toolkit
- Ask the key questions about any new treatment: What are the benefits? What are the risks? What are the alternatives? What happens if I do nothing?
- Ask how long a drug has been on the market and whether there is an older, well-studied option.
- Check Open Payments to see whether your doctor has financial ties to companies whose products they recommend.
- Get a second opinion for major surgeries, serious diagnoses, or expensive long-term treatments.
- Read beyond headlines. Look for independent sources like Cochrane reviews and government health agencies.
- Report side effects to your doctor and to the FDA’s MedWatch program. Patient reports help catch problems early.
- Bring every pill and supplement to your appointments so your doctor can check for interactions.
- Apply the same skepticism to supplements and wellness products. Choose third-party tested brands.
Throughout our blog, we try to model this approach, digging into the evidence on popular remedies such as saw palmetto, berberine, and parasite cleanses. For a historical perspective on medical skepticism, see our earlier post on Dr. Robert Mendelsohn’s critique of the medical industry.
The Bottom Line
Some of the worst health disasters of recent decades were driven by greed and deception, and they deserve to be remembered. But they were also uncovered and punished because people asked hard questions and demanded evidence. You can do the same in your own care. Stay curious, ask questions, look at the money, and insist on evidence, from your doctor and from anyone selling you a cure.
Frequently Asked Questions
Can I trust FDA approval?
FDA approval means a drug has met standards for safety and effectiveness in clinical trials, but rare or long-term side effects may only appear after wide use. That is why reporting side effects matters.
Is it rude to ask my doctor about industry payments?
No. Good doctors welcome questions. You can simply ask why they recommend a particular product and whether alternatives exist.
Are natural remedies safer than drugs?
Not automatically. Some are safe and helpful, some are ineffective, and some are harmful. Each needs to be judged on its evidence.
Where can I find trustworthy health information?
Look for sources that cite studies, disclose funding, and acknowledge uncertainty, such as government health agencies, academic medical centers, and Cochrane reviews.
Sources
- New York State Attorney General. Attorney General James Secures Approval of Purdue Bankruptcy Plan. November 2025.
- Graham DJ, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs. The Lancet, 2005.
- U.S. Attorney’s Office, Northern District of California. Press release on the sentencing of Elizabeth Holmes. November 2022.
- Centers for Medicare & Medicaid Services. Open Payments Data Overview.
- U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program.
This article is for educational purposes and is not medical or legal advice. Never stop a prescribed medication without talking to your doctor.
